Medicare Enrolled
Dr. Jeffrey Toubin, M.D.
Urology Physician · Dallas, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Toubin from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Toubin?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Toubin
Dr. Jeffrey Toubin is an urology physician in Dallas, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Toubin performed 4,032 Medicare services across 1,963 unique beneficiaries.
Between the years covered by Open Payments, Dr. Toubin received a total of $11,034 from 70 pharmaceutical and/or device companies across 512 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Toubin is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 30% volume in TX
$11,034 industry payments
Medicare Practice Summary
Medicare Utilization ↗4,032
Medicare services
Top 30% in TX for urology physician
1,963
Unique beneficiaries
$49
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~212 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Infectious disease DNA/RNA test A laboratory test that uses a specific technique to detect the genetic material of an organism. This method amplifies the target DNA or RNA to identify the presence of the organism. |
949 | $34 | $166 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
694 | $84 | $368 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
613 | $7 | $97 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
437 | $10 | $277 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
360 | $2 | $16 |
| Nucleic acid test for organism quantification A laboratory test that uses nucleic acid detection to measure the amount of a specific organism present in a sample. |
219 | $42 | $222 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
106 | $118 | $565 |
| Yeast/candida DNA test A laboratory test that uses an amplified probe technique to detect the presence of Candida species, a type of yeast, in a patient sample. |
73 | $34 | $123 |
| VRE nucleic acid detection test A laboratory test that uses amplified probe techniques to detect vancomycin-resistant Enterococcus (VRE) DNA in a patient sample. |
73 | $34 | $182 |
| Staphylococcus aureus DNA test A laboratory test that uses DNA amplification to detect the presence of Staphylococcus aureus bacteria in a sample. |
73 | $34 | $153 |
| MRSA nucleic acid detection test A laboratory test that uses amplified probe techniques to detect the genetic material of methicillin-resistant Staphylococcus aureus (MRSA) bacteria. |
73 | $34 | $153 |
| Strep A nucleic acid test, quantification A laboratory test that uses nucleic acid detection to identify and measure the amount of Group A Streptococcus bacteria. |
73 | $41 | $146 |
| Group B Strep DNA test A laboratory test that uses DNA amplification to detect the presence of Group B Streptococcus bacteria. |
73 | $34 | $123 |
| Endoscopic destruction of bladder, urethra, or gland tissue A procedure that uses an endoscope to destroy tissue in the bladder, urethra, or surrounding glands. |
69 | $590 | $4,481 |
| Endoscopic removal of foreign body, stone, or stent from urethra or bladder A procedure to remove a foreign object, stone, or stent from the urethra or bladder using an endoscope. The endoscope is a thin tube with a camera inserted into the urinary tract to locate and extract the item. |
48 | $253 | $837 |
| Gardnerella vaginalis detection and quantification test A laboratory test that detects the presence of Gardnerella vaginalis bacteria and measures the amount present in a sample. |
31 | $41 | $146 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
30 | $181 | $684 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
24 | $19 | $145 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
14 | $48 | $247 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.2% high complexity
15.8% medium
83.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$11,034
Total received (2018-2024)
Avg $1,576/year across 7 years
Top 19% in TX for urology physician
70
Companies
512
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,364 (93.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$670 (6.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,321
2023
$2,306
2022
$2,158
2021
$700
2020
$494
2019
$1,184
2018
$1,870
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Astellas Pharma US Inc
$1,801
Janssen Biotech, Inc.
$1,218
Sumitomo Pharma America, Inc.
$797
Myriad Genetic Laboratories, Inc.
$622
NeoTract Inc.
$528
PFIZER INC.
$528
Antares Pharma, Inc.
$465
Bayer Healthcare Pharmaceuticals Inc.
$357
TOLMAR Pharmaceuticals, Inc.
$245
Boston Scientific Corporation
$230
ABBVIE INC.
$220
Myovant Sciences Inc.
$220
ACCORD HEALTHCARE, INC.
$208
Endo Pharmaceuticals Inc.
$206
ConvaTec Inc.
$204
Blue Earth Diagnostics Limited
$195
BOSTON SCIENTIFIC CORPORATION
$194
Bayer HealthCare Pharmaceuticals Inc.
$184
UROVANT SCIENCES INC
$168
Verity Pharmaceuticals Inc.
$162
Accord Healthcare, Inc.
$155
Coloplast Corp
$140
Medtronic USA, Inc.
$138
Axonics, Inc.
$131
Agiliti Surgical, Inc.
$124
Janssen Products, LP
$100
Alexion Pharmaceuticals, Inc.
$89
Olympus America Inc.
$85
Teleflex LLC
$80
PROCEPT BioRobotics Corporation
$68
Supernus Pharmaceuticals, Inc.
$65
Ferring Pharmaceuticals Inc.
$62
Endo USA, Inc.
$61
Progenics Pharmaceuticals, Inc.
$58
Mission Pharmacal Company
$57
Telix Pharmaceuticals
$57
Smith+Nephew, Inc.
$53
AbbVie, Inc.
$49
Retrophin, Inc.
$47
Sun Pharmaceutical Industries Inc.
$47
Travere Therapeutics, Inc.
$45
Avadel Specialty Pharmaceuticals, LLC
$35
Acerus Pharmaceuticals Corporation
$34
Heron Therapeutics, Inc.
$28
ARGON MEDICAL DEVICES, INC.
$27
Medtronic, Inc.
$26
Photocure Inc
$25
Alnylam Pharmaceuticals Inc.
$22
Dendreon Pharmaceuticals LLC
$21
Amgen Inc.
$20
Novartis Pharmaceuticals Corporation
$20
NxThera, Inc.
$20
Metuchen Pharmaceuticals
$19
PROGENICS PHARMACEUTICALS, INC.
$19
Merck Sharp & Dohme LLC
$19
Allergan Inc.
$19
Avation Medical, Inc.
$18
DENTSPLY IH Inc.
$18
Hollister Incorporated
$18
ABC Home Medical Supply, Inc.
$18
Kerecis Limited
$17
COLOPLAST CORP
$17
Cook Medical LLC
$16
Tolmar, Inc.
$15
UroGen Pharma, Inc.
$15
Avadel Pharmaceuticals (USA), Inc.
$14
Mallinckrodt LLC
$14
ACELL, INC.
$14
180 Medical, Inc.
$13
Janssen Pharmaceuticals, Inc
$9
Top 3 companies account for 34.6% of total payments
Associated products mentioned in payments ›
(815) Thiola · ADVANCE · ADVANTAGE FIT · AMS · AQUABEAM ROBOTIC SYSTEM · AQUABEAM SYSTEM · AVEED · AVYCAZ · Axonics · Axumin · BOTOX · BOTOX THERAPEUTIC · Bulkamid · CAMCEVI · COOK MEDICAL EXTRACTORS · CYSVIEW · Clot Management · DALVANCE · ELIGARD · ERLEADA · Erleada · FIRMAGON · GEMTESA · GENERAL ONCOLOGY · GENERAL BPH · GENTLECATH · GENTLECATH GLIDE · GentleCath · GreenLight XPS · ILLUCCIX · INTERSTIM · JELMYTO · KEYTRUDA · Karbinal ER · Kerecis Omega3 SurgiClose · LITHOVUE EMPOWER · LOCAMETZ · LUPRON DEPOT · LithoVue · LoFric · Lupron · MYRBETRIQ · Myrbetriq · NOCDURNA · Natesto · Noctiva · Nubeqa · OFIRMEV · ORGOVYX · OTREXUP · OXLUMO · Olympus Laser Devices · Otrexup · POSLUMA · PROLARIS · PROVENGE · PYLARIFY · Prolia · RESTORELLE · REZUM · Rezum · Rezum Generator · SPEEDICATH · STRAVIX · STRAVIX PL · SpeediCath · Stendra · Stravix · TITAN · Thiola · Titan · Trelstar · ULTOMIRIS · UROLIFT · Uribel · UroLift · UroLift System · VERIFY · Vivally · XIAFLEX · XTANDI · XYOSTED · Xofigo · Xtandi · YONSA · ZYTIGA · Zynrelef · iTIND System · rezum Generator
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (94%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $274 per 100 Medicare services performed
Geographic Context
Urology physicians within 10 mi
146
Per 100K population
5.6
County median income
$74,149
Nearest hospital
METHODIST DALLAS MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Toubin is a clinical cardiology specialist, with above-average Medicare volume (top 30% in TX), with low-engagement industry engagement in the top 19% of TX peers, with 19 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Toubin experienced with infectious disease dna/rna test?
Based on Medicare claims data, Dr. Toubin performed 949 infectious disease dna/rna test services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Toubin receive payments from pharmaceutical companies?
Yes. Dr. Toubin received a total of $11,034 from 70 companies across 512 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Toubin's costs compare to other urology physicians in Dallas?
Dr. Toubin's average Medicare payment per service is $49. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Toubin) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Dallas
Browse urology physicians in Dallas ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in TX
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in TX
Which TX urology physicians receive the most from drug and device companies.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
Sumitomo Pharma America, Inc. Payments to Doctors
See all physicians who received payments from Sumitomo Pharma America, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology